Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
041
|
Date of Entry 04/04/2016
|
FR Recognition Number
|
7-260
|
Standard | |
CLSI MM03-3rd Edition (Replaces MM03-A2) Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline |
|
Scope/AbstractThis document provides recommendations for cytology laboratories to use in developing preexamination, examination, and postexamination processes and procedures for nongynecological cytology specimen management. |
|
Extent of Recognition
|
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number |
Device Name |
Device Class |
Product Code |
§866.3120 |
Dna-Reagents, Chlamydia
|
Class 1
|
LSK
|
§866.3120 |
Dna Probe, Nucleic Acid Amplification, Chlamydia
|
Class 1
|
MKZ
|
§866.3370 |
Dna-Reagents, Mycobacterium Spp.
|
Class 1
|
LQF
|
§866.3390 |
Dna-Reagents, Neisseria
|
Class 2
|
LSL
|
|
Relevant FDA Guidance and/or Supportive Publications*
Draft Guidance for Industry and FDA Staff Nucleic Acid Based In Vitro Diagnostic Devices for Detection of Microbial Pathogens, Issued December 2005.
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contact
|
Standards Development Organization
|
FDA Specialty Task Group (STG)
|
*These are provided as examples and others may be applicable. |